Your session is about to expire
← Back to Search
Digital Pain Management App for Hospice Care Pain (ePainSupport Trial)
N/A
Waitlist Available
Led By Masako Mayahara, PhD
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2-weeks post baseline
Awards & highlights
ePainSupport Trial Summary
This trialwill test a digital pain management app that could help reduce pain intensity for people with serious illnesses receiving home hospice care.
Who is the study for?
This trial is for adult patients in home hospice care who experience pain, have a life expectancy of at least 2 weeks, and are receiving pain medication. They must speak and read English and have a caregiver willing to participate. Caregivers must also be adults who can communicate about the patient's pain.Check my eligibility
What is being tested?
The trial is testing e-PainSupport, a digital app designed to help manage pain for hospice patients at home. It educates on pain management, allows quick reporting of pain levels to nurses, and aims to ensure adherence to prescribed pain treatments.See study design
What are the potential side effects?
Since this intervention involves using an educational digital application rather than medication or medical procedures, there are no direct physical side effects expected from participating in this study.
ePainSupport Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2-weeks post baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-weeks post baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pain
Secondary outcome measures
Pain
Other outcome measures
Adherence to pain management
Knowledge
Self-Efficacy
ePainSupport Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: e-PainSupport ConditionExperimental Treatment1 Intervention
e-PainSupport is a self-administered, digital pain application. Over the course of the two weeks, caregivers and patients will record the severity of patient's pain and how much pain medicine they use to control patient's pain in the e-PainSupport application.
Group II: Standard Care ConditionActive Control1 Intervention
Patients and caregivers will be given a paper copy of the same list of resources for pain management included in the Education Module of the e-PainSupport condition at baseline.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
e-PainSupport
2021
N/A
~130
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
422 Previous Clinical Trials
163,407 Total Patients Enrolled
3 Trials studying Pain
227 Patients Enrolled for Pain
National Institute of Nursing Research (NINR)NIH
579 Previous Clinical Trials
10,376,258 Total Patients Enrolled
19 Trials studying Pain
3,303 Patients Enrolled for Pain
Masako Mayahara, PhDPrincipal Investigator - Rush University Medical Center
Rush University Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I'm sorry, I cannot summarize the inclusion criteria for caregivers without further information about the specific clinical trial. Can you please provide me with more details?You are taking care of someone who is already enrolled in the study.You cannot participate if your hospice nurse has already enrolled in the study.You have someone who can take care of you for the entire 2-week study.You are expected to live for at least 2 weeks.You are able to tell the research team if you are experiencing pain.You are taking pain medication.You can speak and read English.You are 18 years old or above.Requirements for patients to participate in the study.
Research Study Groups:
This trial has the following groups:- Group 1: e-PainSupport Condition
- Group 2: Standard Care Condition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any vacancies available for prospective participants in this research?
"Absolutely. Per the clinicaltrials.gov website, this study is enlisting volunteers as of now; it was first published on April 21st 2021 and last updated November 14th 2022. It aims to recruit a total of 396 participants from one medical centre."
Answered by AI
What is the approximate size of the cohort involved in this research experiment?
"Affirmative. According to clinicaltrials.gov, this medical research is actively enlisting participants since the trial was published on April 21st 2021 and most recently updated November 14th 2022. This study requires 396 volunteers from a single research centre."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger